Assignee
ARENA PHARM INC
US·153 granted patents·127 pending applications·1,831 citations·filing 1998–2025
Top patents by PatentIndex Score
280 records- 0197US11091435B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in S1P1 receptor-associated disordersARENA PHARM INC·Filed 2020·Granted Aug 17, 2021·11 cites·15 claims
- 0297US10676435B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound 1) for use in SIPI receptor-associated disordersARENA PHARM INC·Filed 2019·Granted Jun 9, 2020·12 cites·25 claims
- 0397US9556149B2Processes for the preparation of pyrazole derivatives useful as modulators of the 5-HT2A serotonin receptorARENA PHARM INC·Filed 2014·Granted Jan 31, 2017·16 cites·21 claims
- 0497US6953787B25HT2C receptor modulatorsARENA PHARM INC·Filed 2003·Granted Oct 11, 2005·79 cites·77 claims
- 0597US6140509ANon-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereofARENA PHARM INC·Filed 1999·Granted Oct 31, 2000·180 cites·1 claims
- 0696US11884626B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disordersARENA PHARM INC·Filed 2021·Granted Jan 30, 2024·3 cites·16 claims
- 0796US11771695B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2021·Granted Oct 3, 2023·4 cites·11 claims
- 0896US7977329B25HT2C receptor modulatorsARENA PHARM INC·Filed 2006·Granted Jul 12, 2011·33 cites·18 claims
- 0996US7884101B23-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2006·Granted Feb 8, 2011·42 cites·2 claims
- 1096US6555339B1Non-endogenous, constitutively activated human protein-coupled receptorsARENA PHARM INC·Filed 1998·Granted Apr 29, 2003·161 cites·2 claims
- 1196US6150393ASmall molecule modulators of non-endogenous, constitutively activated human serotonin receptorsARENA PHARM INC·Filed 1999·Granted Nov 21, 2000·136 cites·12 claims
- 1295US11426377B2Method of treating conditions related to the PGI2 receptorARENA PHARM INC·Filed 2021·Granted Aug 30, 2022·5 cites·22 claims
- 1395US11149292B2Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereofARENA PHARM INC·Filed 2016·Granted Oct 19, 2021·8 cites·21 claims
- 1495US11000500B2Method of treating conditions related to the PGI2 receptorARENA PHARM INC·Filed 2020·Granted May 11, 2021·7 cites·23 claims
- 1595US10479797B2Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related theretoARENA PHARM INC·Filed 2019·Granted Nov 19, 2019·9 cites·30 claims
- 1695US9732039B2Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2015·Granted Aug 15, 2017·17 cites·13 claims
- 1795US7108991B2Human orphan G protein-coupled receptorsARENA PHARM INC·Filed 2003·Granted Sep 19, 2006·38 cites·11 claims
- 1894US11560369B2Crystalline forms and processes for the preparation of cannabinoid receptor modulatorsARENA PHARM INC·Filed 2021·Granted Jan 24, 2023·2 cites·20 claims
- 1994US7838525B2Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2006·Granted Nov 23, 2010·39 cites·69 claims
- 2094US7368539B2Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereofARENA PHARM INC·Filed 2004·Granted May 6, 2008·29 cites·1 claims
- 2194US6846919B2Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereofARENA PHARM INC·Filed 2002·Granted Jan 25, 2005·29 cites·1 claims
- 2294US6107324A5-HT2A receptor inverse agonistsARENA PHARM INC·Filed 1999·Granted Aug 22, 2000·179 cites·7 claims
- 2393US10981895B2Crystalline forms and processes for the preparation of cannabinoid receptor modulatorsARENA PHARM INC·Filed 2018·Granted Apr 20, 2021·4 cites·16 claims
- 2493US10301262B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disordersARENA PHARM INC·Filed 2016·Granted May 28, 2019·11 cites·50 claims
- 2593US10183930B2Crystalline forms and processes for the preparation of cannabinoid receptor modulatorsARENA PHARM INC·Filed 2016·Granted Jan 22, 2019·10 cites·11 claims
- 2693US9447041B2Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereofARENA PHARM INC·Filed 2015·Granted Sep 20, 2016·12 cites·22 claims
- 2793US9273035B2Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2014·Granted Mar 1, 2016·15 cites·26 claims
- 2893US9126932B2Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disordersARENA PHARM INC·Filed 2013·Granted Sep 8, 2015·17 cites·61 claims
- 2993US7514422B25HT2c receptor modulatorsARENA PHARM INC·Filed 2004·Granted Apr 7, 2009·36 cites·54 claims
- 3093US7132426B2Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2004·Granted Nov 7, 2006·56 cites·57 claims
- 3192US11826337B2Method of treating conditions related to the PGI2 receptorARENA PHARM INC·Filed 2022·Granted Nov 28, 2023·1 cites·22 claims
- 3292US11214548B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2019·Granted Jan 4, 2022·3 cites·8 claims
- 3392US10668033B2Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2017·Granted Jun 2, 2020·4 cites·32 claims
- 3492US10632134B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2017·Granted Apr 28, 2020·5 cites·16 claims
- 3592US9522133B2Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disordersARENA PHARM INC·Filed 2015·Granted Dec 20, 2016·9 cites·42 claims
- 3692US9353064B2Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related theretoARENA PHARM INC·Filed 2015·Granted May 31, 2016·9 cites·51 claims
- 3792US9175320B2Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereofARENA PHARM INC·Filed 2014·Granted Nov 3, 2015·15 cites·42 claims
- 3892US6420541B1Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereofARENA PHARM INC·Filed 2000·Granted Jul 16, 2002·40 cites·1 claims
- 3991US10927123B2Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related theretoARENA PHARM INC·Filed 2020·Granted Feb 23, 2021·2 cites·6 claims
- 4091US10688076B2Method of treating conditions related to the PGI2 receptorARENA PHARM INC·Filed 2019·Granted Jun 23, 2020·7 cites·17 claims
- 4191US10662200B2Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related theretoARENA PHARM INC·Filed 2019·Granted May 26, 2020·3 cites·24 claims
- 4291US10537546B2Method of treating conditions related to the PGI2 receptorARENA PHARM INC·Filed 2015·Granted Jan 21, 2020·9 cites·17 claims
- 4391US10059691B2Processes for the preparation of pyrazole derivatives useful as modulators of the 5-HT2A serotonin receptorARENA PHARM INC·Filed 2017·Granted Aug 28, 2018·4 cites·3 claims
- 4491US9867822B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2016·Granted Jan 16, 2018·7 cites·18 claims
- 4591US9492447B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2015·Granted Nov 15, 2016·9 cites·20 claims
- 4691US9328107B2Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2014·Granted May 3, 2016·12 cites·34 claims
- 4791USRE45336EPrimary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2007·Granted Jan 13, 2015·12 cites·22 claims
- 4891US7470699B2Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2004·Granted Dec 30, 2008·41 cites·57 claims
- 4990US12378198B2Crystalline l-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in SIPI receptor-associated disordersARENA PHARM INC·Filed 2023·Granted Aug 5, 2025·0 cites·40 claims
- 5090US9221755B2Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2014·Granted Dec 29, 2015·11 cites·30 claims
Showing the top 50 of 280 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ARENA PHARM INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →